TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action

This publication has 13 references indexed in Scilit:

• Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
  Journal of Clinical Investigation, 1994
• New Directions for Biological Therapy in Rheumatoid Arthritis
  International Archives of Allergy and Immunology, 1994
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
  Molecular Immunology, 1993
• Localization of tumor necrosis factor receptors in the synovial tissue and cartilage‐pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor α
  Arthritis & Rheumatism, 1992
• Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
  Arthritis & Rheumatism, 1992
• Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta
  Clinical and Experimental Immunology, 1992
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis
  Arthritis & Rheumatism, 1991
• INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS
  The Lancet, 1989